ArticleChemical science2017
A pH responsive complexation-based drug delivery system for oxaliplatin.
Open access · diamondAbstract read
In one paragraph
Article in Chemical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 196 citations in OpenAlex.
- Review
- Advanced nanoplatforms for oxaliplatin-based breast cancer therapy: targeted delivery, stimuli-responsive design, and translational challenges.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Article
- Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy.Translational oncology · 2024Review
- Synthetic Receptors for Early Detection and Treatment of Cancer.Biosensors · 2023Review
- Recent Advances in Supramolecular-Macrocycle-Based Nanomaterials in Cancer Treatment.Molecules (Basel, Switzerland) · 2023Review
- A pillar[5]arene-based planar chiral charge-transfer dye with enhanced circularly polarized luminescence and multiple responsive chiroptical changes.Chemical science · 2023Article
- Liposomes loaded with dual clinical photosensitizers for enhanced photodynamic therapy of cervical cancer.RSC advances · 2023Article
- Modular and hierarchical self-assembly of siRNAs into supramolecular nanomaterials for soft and homogeneous siRNA loading and precise and visualized intracellular delivery.Chemical science · 2022Article
- Separation of pyrrolidine from tetrahydrofuran by using pillar[6]arene-based nonporous adaptive crystals.Chemical science · 2022Article
- Enhanced Anticancer Activity of Nedaplatin Loaded onto Copper Nanoparticles Synthesized Using Red Algae.Pharmaceutics · 2022Article
- Research Progress and Prospects for Polymeric Nanovesicles in Anticancer Drug Delivery.Frontiers in bioengineering and biotechnology · 2022Review
- Stimuli-Responsive Amphiphilic Pillar[ACS omega · 2021Review
- GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo-Chemodynamic Combination Therapy.Molecules (Basel, Switzerland) · 2021Article
- Use of Half-Generation PAMAM Dendrimers (G0.5-G3.5) with Carboxylate End-Groups to Improve the DACHPtClMolecules (Basel, Switzerland) · 2021Article
- Selective complexation and efficient separation ofRSC advances · 2020Article
- Multi-spectroscopic monitoring of molecular interactions between an amino acid-functionalized ionic liquid and potential anti-Alzheimer's drugs.RSC advances · 2020Article
- Supramolecular combination chemotherapy: a pH-responsive co-encapsulation drug delivery system.Chemical science · 2020Article
- The Self-Assembly of a Cyclometalated Palladium Photosensitizer into Protein-Stabilized Nanorods Triggers Drug Uptake In Vitro and In Vivo.Journal of the American Chemical Society · 2020Article
- Construction of pillar[4]arene[1]quinone-1,10-dibromodecane pseudorotaxanes in solution and in the solid state.Beilstein journal of organic chemistry · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 2 institutions in 2 countries.
Bin LiDepartment of Chemistry , Center for Supramolecular Chemistry and Catalysis , Shanghai University , Shanghai 200444 , P. R. China . Email: sessler@mail.utexas.edu ; Email: cjli@shu.edu.cn.
Zhao MengState Key Laboratory of Toxicology and Medical Countermeasures , Beijing Institute of Pharmacology and Toxicology , Beijing 100850 , P. R. China . Email: nankaimqb@sina.com.
Qianqian LiDepartment of Chemistry , Center for Supramolecular Chemistry and Catalysis , Shanghai University , Shanghai 200444 , P. R. China . Email: sessler@mail.utexas.edu ; Email: cjli@shu.edu.cn.
Xiayang HuangDepartment of Chemistry , Center for Supramolecular Chemistry and Catalysis , Shanghai University , Shanghai 200444 , P. R. China . Email: sessler@mail.utexas.edu ; Email: cjli@shu.edu.cn.
Ziyao KangState Key Laboratory of Toxicology and Medical Countermeasures , Beijing Institute of Pharmacology and Toxicology , Beijing 100850 , P. R. China . Email: nankaimqb@sina.com.
Huajin DongState Key Laboratory of Toxicology and Medical Countermeasures , Beijing Institute of Pharmacology and Toxicology , Beijing 100850 , P. R. China . Email: nankaimqb@sina.com.
Junyi ChenDepartment of Chemistry , Center for Supramolecular Chemistry and Catalysis , Shanghai University , Shanghai 200444 , P. R. China . Email: sessler@mail.utexas.edu ; Email: cjli@shu.edu.cn.
Ji SunDepartment of Chemistry , Center for Supramolecular Chemistry and Catalysis , Shanghai University , Shanghai 200444 , P. R. China . Email: sessler@mail.utexas.edu ; Email: cjli@shu.edu.cn.
Yansheng DongState Key Laboratory of Toxicology and Medical Countermeasures , Beijing Institute of Pharmacology and Toxicology , Beijing 100850 , P. R. China . Email: nankaimqb@sina.com.
Jian LiDepartment of Chemistry , Center for Supramolecular Chemistry and Catalysis , Shanghai University , Shanghai 200444 , P. R. China . Email: sessler@mail.utexas.edu ; Email: cjli@shu.edu.cn.
Xueshun JiaDepartment of Chemistry , Center for Supramolecular Chemistry and Catalysis , Shanghai University , Shanghai 200444 , P. R. China . Email: sessler@mail.utexas.edu ; Email: cjli@shu.edu.cn.
Jonathan L SesslerDepartment of Chemistry , Center for Supramolecular Chemistry and Catalysis , Shanghai University , Shanghai 200444 , P. R. China . Email: sessler@mail.utexas.edu ; Email: cjli@shu.edu.cn.ORCID 0000-0002-9576-1325
Qingbin MengState Key Laboratory of Toxicology and Medical Countermeasures , Beijing Institute of Pharmacology and Toxicology , Beijing 100850 , P. R. China . Email: nankaimqb@sina.com.
Chunju LiDepartment of Chemistry , Center for Supramolecular Chemistry and Catalysis , Shanghai University , Shanghai 200444 , P. R. China . Email: sessler@mail.utexas.edu ; Email: cjli@shu.edu.cn.
Shanghai University · CNInstitute of Pharmacology · CZ
Funding
No grant is acknowledged in the PubMed record.
Abstract
A responsive drug delivery system (DDS) for oxaliplatin (
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.